Blog
RSS FeedPosted by Michael Wonder on 21 Dec 2016
Decision to list oral betaine for rare disorder
21 December 2016 - PHARMAC is pleased to announce the approval of an agreement with Emerge Health to list oral ...
Posted by Michael Wonder on 20 Dec 2016
Liberals fail to clinch 10-year health deal with provinces
19 December 2016 - Prime Minister Justin Trudeau’s campaign vow to improve federal-provincial relations has suffered a major blow as ...
Posted by Michael Wonder on 20 Dec 2016
Proposal to maintain full subsidy for gefitinib (Iressa) from 1 April 2017
20 December 2016 - PHARMAC is seeking feedback on a proposal to amend the contractual terms of funding for gefitinib ...
Posted by Michael Wonder on 19 Dec 2016
Aussie mums shunning private hospitals due to obscene obstetrics charges
16 December 2016 - Obstetrician charges of up to $10,000 and midwife led care in public hospitals are driving new ...
Posted by Michael Wonder on 19 Dec 2016
Vertex announces German reimbursement agreement for Orkambi (lumacaftor with ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis in people ages 12 and older with two copies of the F508del mutation
19 December 2016 - Vertex Pharmaceuticals today announced it has reached a pricing and reimbursement agreement for Orkambi (lumacaftor with ...
Posted by Michael Wonder on 19 Dec 2016
Review of access to new medicines report
15 December 2016 - The Scottish Government has published Dr Brian Montgomery’s Review of Access to New Medicines, which assesses ...
Posted by Michael Wonder on 19 Dec 2016
A message from the Panel - Review of Pharmacy Remuneration and Regulation
19 December 2016 - In their final communication for the year, the Independent Review Panel conducting the Review of Pharmacy Remuneration ...
Posted by Michael Wonder on 19 Dec 2016
National Health Amendment (Pharmaceutical Benefits) Bill 2016
19 December 2016 - The National Health Amendment (Pharmaceutical Benefits) Bill 2016 was introduced into the House of Representatives on ...
Posted by Michael Wonder on 18 Dec 2016
Summary of submissions and outcomes from the November 2016 PBAC meeting
19 December 2016 - 70 submissions were considered at the July 2016 PBAC meeting (this includes submissions relating to “Other ...
Posted by Michael Wonder on 18 Dec 2016
AFT to re-apply for heart medicine contract after shortages
16 December 2016 - AFT Pharmaceuticals, the Auckland-based drug-maker, will have to re-apply to Pharmac for a heart medicine supply ...
Posted by Michael Wonder on 18 Dec 2016
PBS expenditure and prescriptions for 2015-16
16 December 2016 - The PBS Expenditure and Prescriptions Report 2015-16 is now available. ...
Posted by Michael Wonder on 18 Dec 2016
Proposal to list a range of orthopaedic implants and associated products supplied by Zimmer Biomet New Zealand
16 December 2016 - PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated ...
Posted by Michael Wonder on 18 Dec 2016
New asthma treatments to be listed on Pharmaceutical Benefits Scheme
18 December 2016 - Life-saving new treatments for asthma that currently cost patients $700 a year will be listed on ...
Posted by Michael Wonder on 15 Dec 2016
NICE publishes second appraisal consultation document for brentuximab vedotin
15 December 2016 - The appraisal consultation relates to the use of brentuximab vedotin to treat patients with CD30 positive, ...
Posted by Michael Wonder on 15 Dec 2016
Price disclosure 2017 April cycle outcomes summary
15 December 2016 - The summary of price disclosure price reductions for the 2017 April cycle (second remove originator cycle) has ...